330 related articles for article (PubMed ID: 30949860)
1. Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review.
Burlacu A; Simion P; Nistor I; Covic A; Tinica G
Heart Fail Rev; 2019 Sep; 24(5):793-803. PubMed ID: 30949860
[TBL] [Abstract][Full Text] [Related]
2. Update on Devices for Diastolic Dysfunction: Options for a No Option Condition?
Gupta A; Bailey SR
Curr Cardiol Rep; 2018 Aug; 20(10):85. PubMed ID: 30112586
[TBL] [Abstract][Full Text] [Related]
3. Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.
Kaye DM; Petrie MC; McKenzie S; Hasenfuβ G; Malek F; Post M; Doughty RN; Trochu JN; Gustafsson F; Lang I; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Hausleiter J; Raake P; Jondeau G; Bergmann MW; Spelman T; Aytug H; Ponikowski P; Hayward C;
ESC Heart Fail; 2019 Feb; 6(1):62-69. PubMed ID: 30311437
[TBL] [Abstract][Full Text] [Related]
4. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
[TBL] [Abstract][Full Text] [Related]
6. Left atrial decompression pump for severe heart failure with preserved ejection fraction: theoretical and clinical considerations.
Burkhoff D; Maurer MS; Joseph SM; Rogers JG; Birati EY; Rame JE; Shah SJ
JACC Heart Fail; 2015 Apr; 3(4):275-82. PubMed ID: 25770409
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).
Feldman T; Komtebedde J; Burkhoff D; Massaro J; Maurer MS; Leon MB; Kaye D; Silvestry FE; Cleland JG; Kitzman D; Kubo SH; Van Veldhuisen DJ; Kleber F; Trochu JN; Auricchio A; Gustafsson F; Hasenfuβ G; Ponikowski P; Filippatos G; Mauri L; Shah SJ
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27330010
[TBL] [Abstract][Full Text] [Related]
8. Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial.
Patel RB; Silvestry FE; Komtebedde J; Solomon SD; Hasenfuß G; Litwin SE; Borlaug BA; Price MJ; Kawash R; Hummel SL; Cutlip DE; Leon MB; van Veldhuisen DJ; Rieth AJ; McKenzie S; Bugger H; Mazurek JA; Kapadia SR; Vanderheyden M; Ky B; Shah SJ
JAMA Cardiol; 2024 Jun; 9(6):507-522. PubMed ID: 38630494
[TBL] [Abstract][Full Text] [Related]
9. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.
Shah SJ; Feldman T; Ricciardi MJ; Kahwash R; Lilly S; Litwin S; Nielsen CD; van der Harst P; Hoendermis E; Penicka M; Bartunek J; Fail PS; Kaye DM; Walton A; Petrie MC; Walker N; Basuray A; Yakubov S; Hummel SL; Chetcuti S; Forde-McLean R; Herrmann HC; Burkhoff D; Massaro JM; Cleland JGF; Mauri L
JAMA Cardiol; 2018 Oct; 3(10):968-977. PubMed ID: 30167646
[TBL] [Abstract][Full Text] [Related]
10. Left atrial changes in early stages of heart failure with preserved ejection fraction.
Bytyçi I; Bajraktari G
Echocardiography; 2016 Oct; 33(10):1479-1487. PubMed ID: 27471047
[TBL] [Abstract][Full Text] [Related]
11. New percutaneous interventions in heart failure.
Moscarella E; Brugaletta S; Sabaté M
Minerva Cardioangiol; 2019 Apr; 67(2):145-162. PubMed ID: 29651826
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure.
Søndergaard L; Reddy V; Kaye D; Malek F; Walton A; Mates M; Franzen O; Neuzil P; Ihlemann N; Gustafsson F
Eur J Heart Fail; 2014 Jul; 16(7):796-801. PubMed ID: 24961390
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
[TBL] [Abstract][Full Text] [Related]
14. Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction.
Rosalia L; Ozturk C; Shoar S; Fan Y; Malone G; Cheema FH; Conway C; Byrne RA; Duffy GP; Malone A; Roche ET; Hameed A
JACC Basic Transl Sci; 2021; 6(9-10):772-795. PubMed ID: 34754993
[TBL] [Abstract][Full Text] [Related]
15. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van der Heyden J; Lang I; Petrie MC; Cleland JG; Leon M; Kaye DM;
Lancet; 2016 Mar; 387(10025):1298-304. PubMed ID: 27025436
[TBL] [Abstract][Full Text] [Related]
16. Impaired left atrial systolic function and inter-atrial dyssynchrony may contribute to symptoms of heart failure with preserved left ventricular ejection fraction: A comprehensive assessment by echocardiography.
Liu S; Guan Z; Zheng X; Meng P; Wang Y; Li Y; Zhang Y; Yang J; Jia D; Ma C
Int J Cardiol; 2018 Apr; 257():177-181. PubMed ID: 29506691
[TBL] [Abstract][Full Text] [Related]
17. InterAtrial Shunt Device (IASD®) implantation - a novel treatment method for heart failure with preserved ejection fraction.
Kosowski M; Kübler P; Kołodziej A; Krakowiak B; Kustrzycka-Kratochwil D; Sławin J; Sokolski M; Biegus J; Zymliński R; Banasiak W; Ponikowski P; Reczuch K
Kardiol Pol; 2017; 75(8):736-741. PubMed ID: 28541594
[TBL] [Abstract][Full Text] [Related]
18. Heart Rate-Induced Myocardial Ca
Silverman DN; Rambod M; Lustgarten DL; Lobel R; LeWinter MM; Meyer M
J Am Heart Assoc; 2020 Sep; 9(17):e017215. PubMed ID: 32856526
[TBL] [Abstract][Full Text] [Related]
19. Influence of Left Atrial Function on Exercise Capacity and Left Ventricular Function in Patients With Heart Failure and Preserved Ejection Fraction.
von Roeder M; Rommel KP; Kowallick JT; Blazek S; Besler C; Fengler K; Lotz J; Hasenfuß G; Lücke C; Gutberlet M; Schuler G; Schuster A; Lurz P
Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28360259
[TBL] [Abstract][Full Text] [Related]
20. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
Saksena S; Slee A; Saad M
J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
